Type 1 Diabetes

Revolutionary ‘Inverse Vaccine’ Offers Hope for Autoimmune Disease Treatment

A research team has developed an innovative “inverse vaccine” that could potentially treat autoimmune diseases, including multiple sclerosis (MS), type 1 diabetes, rheumatoid arthritis, and Crohn’s disease. This groundbreaking approach could offer more specificity in treatment, minimizing side effects and enhancing patient safety compared to current treatments that broadly suppress the immune system.

Read More »

Microbiome: Therapeutic Implications, Killarney Conference

An interdisciplinary group of scientists and physicians presented largely unpublished microbiome research at the 2019 Keystone Symposium in an effort to share, inspire, and provoke new ways of thinking. Certain autoimmune diseases, such as ulcerative colitis and type 1 diabetes, exhibit microbiomes that differ from those of healthy individuals.

Read More »